Our investment strategies are specifically developed for venture, growth capital, healthcare, buyout, special situations, and private credit. We deliver outstanding risk-adjusted returns by concentrating on:
- Venture: Startups with differentiated core advantages, high growth potential, asset-light business models, and a vast market opportunity.
- Growth Capital: Enterprises that demonstrate proven growth potential and a competitive edge, aiming to grow through IPO or M&A strategies.
- Healthcare: High-potential startups in sectors such as biotech and pharmaceuticals, med-tech, digital health care, and the broader biomedical and healthcare service sectors.
- Buyout: Capitalizing on M&A opportunities arising from market shifts, with a focus on medium-sized enterprises in Greater China.
- Special Situations: Making opportunistic investments in North America and the Asia-Pacific, spanning both holdings and non-holdings, to optimize risk-adjusted returns.
- Private Credit: Aiming for consistent, high-yield cash returns by backing reputable SMEs, and offering tailored asset portfolios with secure financing structures.
Our Strategic Advisory Group was established in 2017, comprising veteran investment professionals who offer advisory services on private equity fund investments and create tailored programs for regional institutional investors. Later that year, CDIB was formally engaged by KGI Life Insurance Company as its Investment Advisor.
We work closely with our clients to produce customized fund investment programs, with the aim of creating well-balanced and diversified portfolios, establishing strong relationships with best-in-class fund managers, and enhancing investment returns. Our comprehensive end-to-end capabilities provide a fully outsourced solution for clients looking to develop or enhance their private equity exposure.
